Pharming Group NV (PHAR)
9.68
-0.12
(-1.22%)
USD |
NASDAQ |
Oct 06, 16:00
Pharming Group Profit Margin (Quarterly) : 1.77% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.77% |
| March 31, 2026 | -7.20% |
| December 31, 2025 | 4.98% |
| September 30, 2025 | 7.71% |
| June 30, 2025 | 4.94% |
| March 31, 2025 | -18.82% |
| December 31, 2024 | 3.99% |
| September 30, 2024 | -1.38% |
| June 30, 2024 | -1.62% |
| March 31, 2024 | -22.39% |
| December 31, 2023 | -3.33% |
| September 30, 2023 | 5.20% |
| June 30, 2023 | 2.40% |
| March 31, 2023 | -28.70% |
| December 31, 2022 | -26.78% |
| September 30, 2022 | 16.78% |
| June 30, 2022 | 31.39% |
| March 31, 2022 | 7.42% |
| December 31, 2021 | 3.91% |
| September 30, 2021 | -0.79% |
| June 30, 2021 | 11.73% |
| March 31, 2021 | 19.56% |
| December 31, 2020 | 14.59% |
| September 30, 2020 | 16.16% |
| June 30, 2020 | 24.72% |
| Date | Value |
|---|---|
| March 31, 2020 | 17.10% |
| December 31, 2019 | 26.58% |
| September 30, 2019 | 23.03% |
| June 30, 2019 | 16.05% |
| March 31, 2019 | 19.13% |
| December 31, 2018 | 30.16% |
| September 30, 2018 | 13.81% |
| June 30, 2018 | 10.10% |
| March 31, 2018 | 18.62% |
| December 31, 2017 | -128.4% |
| September 30, 2017 | -28.72% |
| June 30, 2017 | -161.1% |
| March 31, 2017 | -37.18% |
| December 31, 2016 | -98.80% |
| September 30, 2016 | -108.5% |
| June 30, 2016 | -109.4% |
| March 31, 2016 | -152.9% |
| December 31, 2015 | -173.1% |
| September 30, 2015 | -74.24% |
| June 30, 2015 | -62.49% |
| March 31, 2015 | -74.61% |
| December 31, 2014 | 75.56% |
| September 30, 2014 | 97.47% |
| June 30, 2014 | -366.8% |
| March 31, 2014 | -1.13K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| ProQR Therapeutics NV | -99.65% |
| NewAmsterdam Pharma Co. NV | -1.73K% |
| argenx SE | -- |
| Nektar Therapeutics | -401.0% |
| ACADIA Pharmaceuticals, Inc. | 10.23% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 3.52% |
| Return on Assets | 1.91% |
| Return on Invested Capital | 2.37% |
| Gross Profit Margin (Quarterly) | 80.56% |
| Operating Margin (Quarterly) | 2.22% |
| Return on Net Operating Assets | 3.33% |